Bicamed 50

Bicamed 50

bicalutamide

Manufacturer:

Hetero Labs

Distributor:

Medicell Pharma
Concise Prescribing Info
Contents
Bicalutamide
Indications/Uses
Advanced prostate cancer in combination w/ LHRH analogue therapy or surgical castration.
Dosage/Direction for Use
Adult male including elderly 1 tab once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Co-administration w/ terfenadine, astemizole or cisapride. Females & childn.
Special Precautions
Monitor blood glucose in patients receiving concomitant LHRH agonists. Perform periodic liver function testing. Co-administration w/ CYP3A4 metabolised drugs. Galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. May affect ability to drive & use machines. Moderate to severe hepatic impairment. Not to be given during pregnancy & lactation.
Adverse Reactions
Anaemia; dizziness; hot flush; abdominal pain, constipation, nausea; haematuria; gynaecomastia & breast tenderness; asthenia, oedema. Decreased appetite; decreased libido, depression; somnolence; MI, cardiac failure; diarrhoea, dyspepsia, flatulence; hepatotoxicity, jaundice, raised transaminases; alopecia, hirsutism/hair regrowth, dry skin, pruritus, rash; erectile dysfunction; chest pain; increased wt.
Drug Interactions
Increased AUC of midazolam. Concomitant use w/ terfenadine, astemizole & cisapride. Caution w/ compd eg, ciclosporin & Ca channel blockers. Increased plasma conc w/ other drugs inhibiting drug oxidation eg, cimetidine & ketoconazole. Closely monitor prothrombin time w/ coumarin anticoagulant eg, warfarin.
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BB03 - bicalutamide ; Belongs to the class of anti-androgens. Used in treatment of neoplastic diseases.
Presentation/Packing
Form
Bicamed 50 FC tab 50 mg
Packing/Price
30's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in